Education
About Us
Working with TipRanks
Follow Us
Definitive Healthcare Corp (DH)
NASDAQ:DH
DH Stock Chart & Stats
$2.74
-$0.06(-1.41%)
At close: 4:00 PM EST
$2.74
-$0.06(-1.41%)
Day’s Range― - ―
52-Week Range$2.15 - $5.68
Previous CloseN/A
Volume69.97K
Average Volume (3M)338.90K
Market Cap
$396.10M
Enterprise Value$517.95M
Total Cash (Recent Filing)$185.92M
Total Debt (Recent Filing)$175.40M
Price to Earnings (P/E)―
Beta1.72
Next Earnings
Feb 19, 2026EPS Estimate
0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding104,086,210
10 Day Avg. Volume311,870
30 Day Avg. Volume338,897
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)1.08
Price to Sales (P/S)1.90
P/FCF Ratio10.46
Enterprise Value/Market Cap1.31
Enterprise Value/Revenue2.14
Enterprise Value/Gross Profit2.74
Enterprise Value/Ebitda-2.40
Forecast
1Y Price Target
$3.23Price Target Upside17.88% Upside
Rating ConsensusHold
Number of Analyst Covering7
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Customer AcquisitionThe firm added 10 net new enterprise accounts, marking the first quarterly increase since Q4/23.
Financial PerformanceDefinitive Healthcare reported positive third quarter earnings, with revenue and adjusted EBITDA both tracking Street expectations.
Market PerformanceThe company has successfully gained key customer wins, including a large multi-national bio-pharma company and a medical device company.
Bears Say
Future Growth ChallengesGrowth will continue to decline in 2026 and margins will come in a bit, making it hard for Definitive to show operating leverage.
Macro-environment ChallengesThe biggest challenges facing DH are the overall macro-environment, some elongated decision-making processes, y/y declines in revenue, and continuing attrition.
Retention IssuesThe net dollar retention for the full year is expected to decline modestly due to ongoing pressures.
Definitive Healthcare Corp News
DH FAQ
What was Definitive Healthcare Corp’s price range in the past 12 months?
Definitive Healthcare Corp lowest stock price was $2.15 and its highest was $5.68 in the past 12 months.
What is Definitive Healthcare Corp’s market cap?
Definitive Healthcare Corp’s market cap is $396.10M.
When is Definitive Healthcare Corp’s upcoming earnings report date?
Definitive Healthcare Corp’s upcoming earnings report date is Feb 19, 2026 which is in 93 days.
How were Definitive Healthcare Corp’s earnings last quarter?
Definitive Healthcare Corp released its earnings results on Nov 06, 2025. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.056 by $0.014.
Is Definitive Healthcare Corp overvalued?
According to Wall Street analysts Definitive Healthcare Corp’s price is currently Undervalued.
Does Definitive Healthcare Corp pay dividends?
Definitive Healthcare Corp does not currently pay dividends.
What is Definitive Healthcare Corp’s EPS estimate?
Definitive Healthcare Corp’s EPS estimate is 0.06.
How many shares outstanding does Definitive Healthcare Corp have?
Definitive Healthcare Corp has 104,086,210 shares outstanding.
What happened to Definitive Healthcare Corp’s price movement after its last earnings report?
Definitive Healthcare Corp reported an EPS of $0.07 in its last earnings report, beating expectations of $0.056. Following the earnings report the stock price went up 10.566%.
Which hedge fund is a major shareholder of Definitive Healthcare Corp?
Currently, no hedge funds are holding shares in DH
Definitive Healthcare Corp Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.79%
12-Months-Change
Fundamentals
Return on Equity
-47.69%
Trailing 12-Months
Asset Growth
-45.86%
Trailing 12-Months
Company Description
Definitive Healthcare Corp
Definitive Healthcare Corp (DH) is a leading provider of data and analytics solutions for the healthcare industry. The company specializes in delivering comprehensive information on healthcare providers, payers, and patients, enabling clients to make informed decisions. Its core products include a robust platform that aggregates vast datasets, offering insights into market dynamics, provider performance, and healthcare trends. DH serves a diverse clientele, including life sciences companies, healthcare providers, and payers, helping them to optimize their strategies and operations.
DH Company Deck
DH Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook. While Definitive Healthcare reported strong profitability and cash flow, as well as growth in enterprise customers and improvements in retention rates, it faced challenges with a decline in revenue and ongoing pressure in the life sciences segment. The strategic partnerships and operational efficiencies are positive indicators, but the revenue decline and macroeconomic uncertainties temper the sentiment.View all DH earnings summariesDH Stock 12 Month Forecast
Average Price Target
$3.23
▲(17.88% Upside)
Technical Analysis
Ownership Overview
8.70% Insiders
5.12% Mutual Funds
0.18% Other Institutional Investors
80.71% Public Companies and
Individual Investors